ST
ACAD icon

Spot Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

Spot Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,000
Closed -$288K – 2844
2016
Q4 		$288K Buy
+10,000
New +$265K 0.01% 1721
2016
Q2 		– Sell
-24,000
Closed -$671K – 3260
2016
Q1 		$671K Sell
24,000
-47,000
-66% -$1.02M 0.01% 1364
2015
Q4 		$2.53M Buy
71,000
+37,800
+114% +$1.33M 0.03% 854
2015
Q3 		$1.1M Buy
+33,200
New +$1.38M 0.01% 1508
2015
Q2 		– Sell
-31,100
Closed -$1.01M – 3807
2015
Q1 		$1.01M Buy
31,100
+4,500
+17% +$155K 0.01% 1587
2014
Q4 		$845K Sell
26,600
-20,200
-43% -$573K 0.01% 1994
2014
Q3 		$1.16M Buy
46,800
+15,600
+50% +$365K 0.01% 1992
2014
Q2 		$705K Sell
31,200
-14,100
-31% -$294K ﹤0.01% 2408
2014
Q1 		$1.1M Sell
45,300
-23,500
-34% -$594K 0.01% 1961
2013
Q4 		$1.72M Buy
68,800
+8,700
+14% +$205K 0.01% 1603
2013
Q3 		$1.65M Buy
60,100
+7,200
+14% +$151K 0.01% 1529
2013
Q2 		$960K Buy
+52,900
New +$729K 0.01% 1931

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Spot Trading's ACAD Position: Q4 2016 in Review

Spot Trading sold out of Acadia Pharmaceuticals (ACAD) in Q4 2016, closing a stake of 7,701 shares — an estimated $204K sold.

Spot Trading first reported a position in ACAD in Q2 2013 and held it in 13 quarters. The position peaked at $513K in Q2 2013. 225 funds tracked by Wall St. Rank hold ACAD as of Q4 2016.

  • Spot Trading reported no remaining Acadia Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 7,701 Acadia Pharmaceuticals shares in Q4 2016, an estimated $204K.
  • Spot Trading first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • Spot Trading's Acadia Pharmaceuticals position peaked at $513K in Q2 2013.
  • 225 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.